Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on November 6, 2026

Nov. 6, 2026

Classroom to International Co-productions: Virtual Production Studio Launched at Curtin University

Indeterminate EIN Presswire

Nov. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Nov. 6, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

KPI Partners Inaugurates Expanded Hyderabad Office to Scale Agentic and Enterprise AI Delivery

Indeterminate EIN Presswire

Nov. 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

‘Legacy Does Not Happen by Chance’: IPC President Lauds Tokyo Five Years after Paralympic Games

Indeterminate EIN Presswire

Nov. 6, 2026

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Business Reporter: From ore to value

Indeterminate EIN Presswire

Nov. 6, 2026

Identity and Biometric Authentication Technologies Provider BIO-key Hosts Q3 Investor Call Friday, November 13 at 10am ET

Indeterminate GlobeNewswire

Nov. 6, 2026

Wegweisende Therapie bei fortgeschrittener Herzinsuffizienz: Der wissenschaftliche Mitgründer von Repairon, Prof. Wolfram-Hubertus Zimmermann, erhält den „Galenus-von-Pergamon“-Preis 2026 für herausragende pharmakologische Grundlagenforschung

Indeterminate GlobeNewswire

Nov. 6, 2026

Une approche thérapeutique innovante pour le traitement de l’insuffisance cardiaque avancée : le professeur Wolfram-Hubertus Zimmermann, cofondateur scientifique de Repairon, reçoit le prix « Galenus-von-Pergamon » 2026 pour ses travaux exceptionnels d…

Indeterminate GlobeNewswire

Nov. 6, 2026

Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

Tactfolio Inc. Launches AI-Compatible Platform for Building, Backtesting, and Automating Trading Strategies

Indeterminate GlobeNewswire

Nov. 6, 2026

Crusoe Announces Wyoming Data Center Campus Update

Indeterminate GlobeNewswire

Nov. 6, 2026

Equator Pure Nature CEO Peter Wainman Spotlighted as the 'Green Tony Stark' at Tatler Asia Gen.T Summit

Indeterminate EIN Presswire